Rudolf Lucas is currently working as a Professor
at the Augusta University Medical College of Georgia. Educated as an engineer
in Biotechnology from the University of Brussels, Belgium, he took postdoctoral
positions at the University Medical Center, Geneva, Switzerland and the
Weizmann Institute for Science, Israel. Before becoming Associate Professor at
MCG in 2007, he worked as vice chair Biochemical pharmacology at the University
of Konstanz, Germany and as professor Medical Biotechnology at the university
of Applied Sciences, Krems, Austria. The main research focus of his laboratory
over the past 20 years is the study of the (patho)physiological mechanisms
involved in endothelial inflammation, apoptosis and barrier dysfunction. As
such, they have identified a TNF-derived peptide, the TIP peptide, which mimics
the lectin-like domain of the cytokine, which is spatially distinct from the TNF
receptor binding sites.
Rudolf Lucas is currently working as a Professor
at the Augusta University Medical College of Georgia. Educated as an engineer
in Biotechnology from the University of Brussels, Belgium, he took postdoctoral
positions at the University Medical Center, Geneva, Switzerland and the
Weizmann Institute for Science, Israel. Before becoming Associate Professor at
MCG in 2007, he worked as vice chair Biochemical pharmacology at the University
of Konstanz, Germany and as professor Medical Biotechnology at the university
of Applied Sciences, Krems, Austria. The main research focus of his laboratory
over the past 20 years is the study of the (patho)physiological mechanisms
involved in endothelial inflammation, apoptosis and barrier dysfunction. As
such, they have identified a TNF-derived peptide, the TIP peptide, which mimics
the lectin-like domain of the cytokine, which is spatially distinct from the TNF
receptor binding sites.